InterHealth Nutraceuticals’ research poster, which summarized data on the impact of Zychrome® on maintaining healthy insulin levels, took first place honors at the 2014 Scripps Natural Supplement Conference in San Diego. Zychrome is InterHealth’s newest patent-pending, chromium containing supplement ingredient. The post-hoc data was derived from a randomized, double-blind, placebo-controlled study published in 2012 in the journal Molecular Nutrition and Food Research. The abstract will be published in the Journal of Alternative and Complimentary Medicine later this year. 

In the study, subjects were stratified in order to determine how Zychrome impacts healthy insulin levels when controlling for medication used to manage glucose levels. The results of this post-hoc assessment showed that Zychrome had a statistically significant impact on healthy insulin levels versus placebo. The research was presented by InterHealth’s senior scientist, Francis Lau, Ph.D. on January 31, 2014. Zychrome received the 2012 NutrAward for best new ingredient. 

This award marks the second year in a row that clinical research by InterHealth has received top honors. Last year, InterHealth’s research on the joint-health ingredient, UC-II®, was awarded first place honors. “We were elated to hear the good news and are grateful to Scripps for continuing to host this important educational event," said Dr. James Lugo, vice president of business development and research.

“This success is a clear signal that the research done by InterHealth continues to gain recognition within the supplements industry as cutting edge and high quality work," stated Paul Dijkstra, president and CEO of InterHealth.